Home  >  Products  >  CDS1 (CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1) Blocking Peptide (the N terminal of CDS1)(100ug)
CDS1 (CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1) Blocking Peptide (the N terminal of CDS1)(100ug)

CDS1 (CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1) Blocking Peptide (the N terminal of CDS1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CDS1 Antibody(ARP45071_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP45071
Size: 100ug
Weight: 53kDa
Gene: 1040
Format: Lyophilized powder
Target: Breakdown products of phosphoinositides are ubiquitous second messengers that function downstream of many G protein-coupled receptors and tyrosine kinases regulating cell growth, calcium metabolism, and protein kinase C activity. CDS1 is an enzyme which regulates the amount of phosphatidylinositol available for signaling by catalyzing the conversion of phosphatidic acid to CDP-diacylglycerol. This enzyme is an integral membrane protein localized to two subcellular domains, the matrix side of the inner mitochondrial membrane where it is thought to be involved in the synthesis of phosphatidylglycerol and cardiolipin and the cytoplasmic side of the endoplasmic reticulum where it functions in phosphatidylinositol biosynthesis.
Alternative names: CDS
See Full Product Listings >